Acanthosis Nigricans
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
64
|
11
|
0.100 |
None |
|
0 |
|
|
|
Marked muscular hypertrophy
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
Pancreatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
502
|
80
|
0.100 |
None |
|
0 |
|
|
|
Polycystic Ovary Syndrome
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
988
|
363
|
0.100 |
None |
|
0 |
|
|
|
Calf muscle hypertrophy
|
phenotype |
|
Finding
|
46
|
5
|
0.100 |
None |
|
0 |
|
|
|
Decreased serum leptin
|
phenotype |
|
Finding
|
8
|
|
0.100 |
None |
|
0 |
|
|
|
Hepatomegaly
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Finding
|
523
|
30
|
0.100 |
None |
|
0 |
|
|
|
Loss of gluteal subcutaneous adipose tissue
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
Decreased adiponectin level
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
Loss of subcutaneous adipose tissue in limbs
|
phenotype |
|
Finding
|
11
|
|
0.100 |
None |
|
0 |
|
|
|
Familial Partial Lipodystrophy, Type 3
|
disease |
Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
10
|
14
|
0.300 |
None |
|
0 |
|
|
|
Familial Partial Lipodystrophy, Type 2
|
disease |
Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
16
|
23
|
0.300 |
None |
|
0 |
|
|
|
Familial Partial Lipodystrophy, Type 1
|
disease |
Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
9
|
|
0.300 |
None |
|
0 |
|
|
|
Oligomenorrhea
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
37
|
1
|
0.100 |
None |
|
0 |
|
|
|
Diabetes
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
2359
|
710
|
0.010 |
None |
< 0.001 |
1 |
|
2008 |
2008 |
Diabetes Mellitus
|
group |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
2803
|
824
|
0.020 |
None |
0.500 |
2 |
|
2008 |
2019 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.090 |
None |
1.000 |
9 |
|
2009 |
2019 |
Steatohepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1143
|
75
|
0.170 |
None |
1.000 |
7 |
|
2013 |
2020 |
Fatty Liver
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
875
|
35
|
0.160 |
None |
1.000 |
6 |
|
2013 |
2020 |
Diabetes Mellitus, Non-Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
3134
|
2672
|
0.030 |
None |
1.000 |
3 |
|
2010 |
2019 |
Alcoholic Steatohepatitis
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
30
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Obesity, Visceral
|
phenotype |
Nutritional and Metabolic Diseases
|
Sign or Symptom
|
55
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5
|
disease |
|
Disease or Syndrome
|
1
|
1
|
0.600 |
limited |
1.000 |
1 |
1
|
2009 |
2009 |
Partial lipodystrophy
|
disease |
Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
14
|
11
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Fatty Liver Disease
|
disease |
|
Disease or Syndrome
|
741
|
81
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |